1.
Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study. Biomol Biomed [Internet]. 2024 Oct. 17 [cited 2025 Feb. 11];24(6):1776–1784. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10512